Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩38.77T | 78.1x | 2.61 | ₩175,000 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.9% Upside | Upgrade to Pro+ | |
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩5.98T | -386.3x | -20.5 | ₩253,500 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩4.83T | 3,220.7x | 29.97 | ₩131,600 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.2% Upside | Upgrade to Pro+ | |
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩4.76T | -247.8x | -5.14 | ₩85,800 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.1% Downside | Upgrade to Pro+ | |
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.63T | -40.7x | 0.12 | ₩43,850 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.87T | -71.4x | 7.37 | ₩173,500 | 8.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38% Upside | Upgrade to Pro+ | |
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.8T | -35.2x | 0.43 | ₩89,500 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curiox BioSystems | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.17T | -29.5x | 0.39 | ₩67,300 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.13T | -88.7x | 0.54 | ₩24,500 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.09T | -15.7x | 2.17 | ₩16,980 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
G2GBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩922.9B | ₩166,300 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Onconic Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩806.71B | 63.4x | 2 | ₩18,370 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -31.1% Downside | Upgrade to Pro+ | |
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩712.49B | 3,643.4x | -8.24 | ₩31,550 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orum Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩688.71B | -47.7x | 0.75 | ₩32,150 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NKMAX | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩684.87B | -0.2 | ₩3,685 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
JS Link | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩645.41B | -27.2x | 0.67 | ₩20,100 | -7.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩577.57B | -36.5x | -4.5 | ₩37,300 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩560.83B | -14.9x | ₩38,750 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Rokit Healthcare | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩530.27B | -19.2x | -2.23 | ₩34,800 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩520.46B | 40.7x | 0.59 | ₩56,100 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Proteina | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩520.22B | ₩44,550 | -6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩517.91B | -29.4x | ₩39,050 | -14.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩492.39B | -5x | 0 | ₩15,690 | 8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩477.46B | -58.8x | -1.73 | ₩19,130 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ImmuneOncia Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩470.78B | -58.7x | ₩6,160 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩426.82B | -19.1x | -0.92 | ₩3,030 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩345.08B | -20.9x | 1.75 | ₩13,080 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3Billion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩275.34B | -42.9x | 1.89 | ₩8,790 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OrganoidSciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩247.44B | -15.7x | ₩36,050 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩240.13B | -4.2x | ₩5,190 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
PharmAbcine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩233.76B | -0.85 | ₩2,915 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩220.84B | -8.3x | 0.23 | ₩7,670 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩207.22B | ₩8,840 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩194.05B | -4.5x | 0.26 | ₩3,500 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HEM Pharma | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩193.68B | ₩26,550 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | ₩189.15B | -3.5x | -0.11 | ₩2,170 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nov Meta Pharma | KONEX | Healthcare | Biotechnology & Medical Research | ₩166B | ₩13,700 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩165.66B | -25.5x | -0.37 | ₩15,150 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tiumbio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩164.79B | -15x | -0.36 | ₩6,000 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ADM Korea | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩158.57B | -6.6x | 0.01 | ₩3,215 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prestige Biopharma | Seoul | Healthcare | Biotechnology & Medical Research | ₩155.05B | 35.7x | 0.04 | ₩12,740 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Parataxis Korea | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩143.23B | -5.4x | -0.13 | ₩1,586 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩142.27B | -4.6x | -0.1 | ₩4,765 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bio CND | KONEX | Healthcare | Biotechnology & Medical Research | ₩141.52B | ₩33,450 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩133.16B | -15.3x | -0.2 | ₩3,990 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kang Stem Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩132.52B | -7.3x | ₩1,416 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CJ Bioscience | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩125.82B | -3.5x | 0.34 | ₩9,440 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ENCell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩124.06B | -6.6x | ₩12,360 | 8.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩120.29B | -21.7x | 32.4 | ₩3,700 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩111.75B | -12.8x | 0.43 | ₩1,312 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |